Skip to main content

局部麻醉軟膏含有利多卡因,按照《防毒包裝法》(PPPA)的規定,包裝必須防止兒童開啟。但是該軟膏包裝不能防止兒童開啟,對幼兒構成中毒風險。

  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream - Package Front
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream - Code, UPC and Batch Number
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream - Expiration Date
  • Recalled Scalpa Numb Maximum Strength Topical Anesthestic Cream – Side View
Name of Product:
局部麻醉軟膏含有利多卡因,按照《防毒包裝法》(PPPA)的規定,包裝必須防止兒童開啟。但是該軟膏包裝不能防止兒童開啟,對幼兒構成中毒風險。
Hazard:

局部麻醉軟膏含有利多卡因,按照《防毒包裝法》(PPPA)的規定,包裝必須防止兒童開啟。但是該軟膏包裝不能防止兒童開啟,對幼兒構成中毒風險。

補救措施:
Refund
Recall Date:
一月 14, 2021

產品召回細節

Manufactured In:
China
產品召回號碼:
21-719

请注意:各位委员会委员对相关题目可能会发表声明。请访问www.cpsc.gov/commissioners搜寻这一或其它题目的相关声明。

If you are experiencing issues with a recall remedy or believe a company is being non-responsive to your remedy request, please use this form and explain the situation to CPSC.
About the U.S. CPSC

The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.

Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.

For lifesaving information:
Choose Your Recall Emails Get Notified About Each Recall via Email.
Report an unsafe product